Zhang Jing-Jing, Ni Ping, Song Yi, Gao Man-Jun, Guo Xi-Ying, Zhao Bao-Qing
Medicine Research Institute & Hubei Key Laboratory of Diabetes and Angiopathy, Xianning, Hubei, China.
Schools of Pharmacy and Hubei University of Science and Technology, Xianning, China.
Cell Death Discov. 2024 Oct 10;10(1):433. doi: 10.1038/s41420-024-02205-x.
Diabetes mellitus is a metabolic disorder with persistent hyperglycemia caused by a variety of underlying factors. Chronic hyperglycemia can lead to diverse serious consequences and diversified complications, which pose a serious threat to patients. Among the major complications are cardiovascular disease, kidney disease, diabetic foot ulcers, diabetic retinopathy, and neurological disorders. Heme oxygenase 1 (HO-1) is a protective enzyme with antioxidant, anti-inflammatory and anti-apoptotic effects, which has been intensively studied and plays an important role in diabetic complications. By inducing the expression and activity of HO-1, it can enhance the antioxidant, anti-inflammatory, and anti-apoptotic capacity of tissues, and thus reduce the degree of damage in diabetic complications. The present study aims to review the relationship between HO-1 and the pathogenesis of diabetes and its complications. HO-1 is involved in the regulation of macrophage polarization and promotes the M1 state (pro-inflammatory) towards to the M2 state (anti-inflammatory). Induction of HO-1 expression in dendritic cells inhibits them maturation and secretion of pro-inflammatory cytokines and promotes regulatory T cell (T cell) responses. The induction of HO-1 can reduce the production of reactive oxygen species, thereby reducing oxidative stress and inflammation. Besides, HO-1 also has an important effect in novel programmed cell death such as pyroptosis and ferroptosis, thereby playing a protective role against diabetes. In conclusion, HO-1 plays a significant role in the occurrence and development of diabetic complications and is closely associated with a variety of complications. HO-1 is anticipated to serve as a novel target for addressing diabetic complications, and it holds promise as a potential therapeutic agent for diabetes and its associated complications. We hope to provide inspiration and ideas for future studies in the mechanism and targets of HO-1 through this review.
糖尿病是一种由多种潜在因素导致持续性高血糖的代谢紊乱疾病。慢性高血糖会引发各种严重后果和多样的并发症,对患者构成严重威胁。主要并发症包括心血管疾病、肾脏疾病、糖尿病足溃疡、糖尿病视网膜病变和神经紊乱。血红素加氧酶1(HO-1)是一种具有抗氧化、抗炎和抗凋亡作用的保护酶,已得到深入研究且在糖尿病并发症中发挥重要作用。通过诱导HO-1的表达和活性,可增强组织的抗氧化、抗炎和抗凋亡能力,从而减轻糖尿病并发症中的损伤程度。本研究旨在综述HO-1与糖尿病及其并发症发病机制之间的关系。HO-1参与巨噬细胞极化的调控,促进其从M1状态(促炎)向M2状态(抗炎)转变。在树突状细胞中诱导HO-1表达可抑制其成熟及促炎细胞因子的分泌,并促进调节性T细胞(T细胞)反应。诱导HO-1可减少活性氧的产生,从而减轻氧化应激和炎症。此外,HO-1在诸如焦亡和铁死亡等新型程序性细胞死亡中也具有重要作用,进而对糖尿病起到保护作用。总之,HO-1在糖尿病并发症的发生和发展中发挥着重要作用,且与多种并发症密切相关。HO-1有望成为解决糖尿病并发症的新靶点,作为糖尿病及其相关并发症的潜在治疗药物具有广阔前景。我们希望通过本综述为未来关于HO-1机制和靶点的研究提供启发和思路。